There are many dystrophies related corneal endothelium resulting in edema, loss of transparency and blindness, finally. Currently, transplantation is only surgical treatment for patients with these corneal endothelial dystrophies, however, the limitation of transplantation is the absolute deficiency of donor cornea. Very recently, to overcome this issue of limited supply of donor cornea, regenerative medicine including stem cell therapy and tissue engineering has been widely attempted and success for human clinical trial.
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